Crossbred Bovine/Cattle — FDA Adverse Event Profile

Crossbred Bovine/Cattle Pet Health Insights

Across the FDA Center for Veterinary Medicine adverse event database, Crossbred Bovine/Cattle accounts for 1,357 submitted reports and currently ranks #91 by report volume within the cattle population. Of those reports, 674 involved a death outcome — a 4970.0% case-fatality figure calculated directly from the underlying FDA records rather than from external mortality studies. The mean age at time of reporting is 1.1 years, with an average recorded body weight of 259.3 kg (571.8 lbs). These figures reflect the voluntary reporting pool only and should be read alongside breed popularity, veterinary access, and owner awareness — all of which shape how many events ever reach the FDA.

The most frequently reported clinical signs for Crossbred Bovine/Cattle are Death (508 reports), Lack of efficacy (bacteria) - NOS (209 reports), Lack of efficacy - NOS (163 reports), together capturing a substantial share of the top-reaction traffic seen in this breed's record. On the product side, Monensin Sodium appears in 131 reports and is the single most-referenced drug, followed by Ivermectin (116) and Moxidectin (115). Counts like these surface which therapeutic classes dominate the reporting stream — useful context when comparing reactions across breeds of the same cattle species.

Outcome coding on the 1,315 reports with a recorded status is dominated by Died (50.5% of coded outcomes). Annual submission volume ranges from 2,010 to 2,025 reports across the 16 years on file, indicating the reporting trend is shaped as much by awareness cycles as by underlying clinical events. Because FDA adverse event reports describe correlation rather than causation, these numbers are most useful as a signal of where to ask further questions with a veterinarian — not as a standalone risk score for any individual cattle.